HK1019710A1 - Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient - Google Patents
Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredientInfo
- Publication number
- HK1019710A1 HK1019710A1 HK99105007A HK99105007A HK1019710A1 HK 1019710 A1 HK1019710 A1 HK 1019710A1 HK 99105007 A HK99105007 A HK 99105007A HK 99105007 A HK99105007 A HK 99105007A HK 1019710 A1 HK1019710 A1 HK 1019710A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- helicobacter pylori
- active ingredient
- compositions containing
- methylcarbapenem derivatives
- pylori compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/04—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11444896 | 1996-05-09 | ||
PCT/JP1997/001542 WO1997041853A1 (fr) | 1996-05-09 | 1997-05-08 | Compositions de lutte contre helicobacter pylori contenant des derives de 1-methylcarbapenem en tant qu'ingredient actif |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1019710A1 true HK1019710A1 (en) | 2000-02-25 |
Family
ID=14637995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99105007A HK1019710A1 (en) | 1996-05-09 | 1999-11-03 | Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient |
Country Status (17)
Country | Link |
---|---|
US (1) | US6180621B1 (xx) |
EP (1) | EP0913151B1 (xx) |
KR (1) | KR20000005535A (xx) |
CN (1) | CN1101189C (xx) |
AT (1) | ATE223216T1 (xx) |
AU (1) | AU711128C (xx) |
CA (1) | CA2253860A1 (xx) |
CZ (1) | CZ287902B6 (xx) |
DE (1) | DE69715208T2 (xx) |
DK (1) | DK0913151T3 (xx) |
ES (1) | ES2180972T3 (xx) |
HK (1) | HK1019710A1 (xx) |
NO (1) | NO985202L (xx) |
NZ (1) | NZ332687A (xx) |
PT (1) | PT913151E (xx) |
RU (1) | RU2173147C2 (xx) |
WO (1) | WO1997041853A1 (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11335269A (ja) * | 1998-05-19 | 1999-12-07 | Hisamitsu Pharmaceut Co Inc | 遺伝子関連医薬の経口投与固形製剤 |
KR20010079713A (ko) * | 1998-09-10 | 2001-08-22 | 마쓰자와 도로, 하야시 지로 | 카르바페넴 화합물 |
BR0107713A (pt) | 2000-01-18 | 2002-11-19 | Vertex Pharma | Inibidores de girase e usos dos mesmos |
MXPA03008056A (es) * | 2001-03-05 | 2004-10-15 | Johnson & Johnson | Composiciones farmaceuticas liquidas con sabor oculto. |
US7670624B2 (en) * | 2004-01-29 | 2010-03-02 | Astella Pharma Inc. | Gastrointestinal-specific multiple drug release system |
CN101260108B (zh) * | 2007-03-11 | 2010-06-02 | 山东轩竹医药科技有限公司 | 巯基吡咯烷酮碳青霉烯类衍生物 |
US10519161B2 (en) | 2012-10-29 | 2019-12-31 | Southern Methodist University | Methods of generating beta-lactamase resistant carbapenem compounds |
US9394634B2 (en) | 2014-03-20 | 2016-07-19 | Arun Agarwal | Woven shielding textile impervious to visible and ultraviolet electromagnetic radiation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2708576B2 (ja) | 1988-11-08 | 1998-02-04 | 第一製薬株式会社 | カルバペネム誘導体 |
CA2050255C (en) | 1990-09-07 | 1997-02-04 | Tameo Iwasaki | 1-methylcarbapenem derivatives and process for preparation thereof |
FI920206A0 (fi) * | 1992-01-17 | 1992-01-17 | Pekka Untamo Heino | Medicinsk anvaendning, medicinskt foerfarande och preparat. |
EP0599512B1 (en) * | 1992-11-17 | 1999-03-24 | Sankyo Company Limited | Crystalline carbapenem derivative |
AU682510B2 (en) | 1993-07-01 | 1997-10-09 | Pfizer Japan Inc. | 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives |
JP3266994B2 (ja) | 1993-07-28 | 2002-03-18 | 株式会社ニコン | 反射型マスク |
JPH07126189A (ja) * | 1993-09-09 | 1995-05-16 | Takeda Chem Ind Ltd | 抗潰瘍併用療法用製剤 |
EP0642797B1 (en) * | 1993-09-09 | 2000-05-17 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
-
1997
- 1997-05-08 NZ NZ332687A patent/NZ332687A/xx unknown
- 1997-05-08 KR KR1019980708335A patent/KR20000005535A/ko not_active Application Discontinuation
- 1997-05-08 PT PT97918382T patent/PT913151E/pt unknown
- 1997-05-08 CA CA002253860A patent/CA2253860A1/en not_active Abandoned
- 1997-05-08 DE DE69715208T patent/DE69715208T2/de not_active Expired - Fee Related
- 1997-05-08 RU RU98120485/14A patent/RU2173147C2/ru not_active IP Right Cessation
- 1997-05-08 CZ CZ19983635A patent/CZ287902B6/cs not_active IP Right Cessation
- 1997-05-08 AT AT97918382T patent/ATE223216T1/de not_active IP Right Cessation
- 1997-05-08 DK DK97918382T patent/DK0913151T3/da active
- 1997-05-08 EP EP97918382A patent/EP0913151B1/en not_active Expired - Lifetime
- 1997-05-08 WO PCT/JP1997/001542 patent/WO1997041853A1/ja not_active Application Discontinuation
- 1997-05-08 ES ES97918382T patent/ES2180972T3/es not_active Expired - Lifetime
- 1997-05-08 AU AU26515/97A patent/AU711128C/en not_active Ceased
- 1997-05-08 CN CN97196245A patent/CN1101189C/zh not_active Expired - Fee Related
-
1998
- 1998-11-06 US US09/187,680 patent/US6180621B1/en not_active Expired - Fee Related
- 1998-11-06 NO NO985202A patent/NO985202L/no not_active Application Discontinuation
-
1999
- 1999-11-03 HK HK99105007A patent/HK1019710A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2253860A1 (en) | 1997-11-13 |
CZ287902B6 (cs) | 2001-03-14 |
NZ332687A (en) | 2000-05-26 |
EP0913151B1 (en) | 2002-09-04 |
AU711128C (en) | 2002-11-07 |
CN1225011A (zh) | 1999-08-04 |
PT913151E (pt) | 2002-11-29 |
CN1101189C (zh) | 2003-02-12 |
KR20000005535A (ko) | 2000-01-25 |
ES2180972T3 (es) | 2003-02-16 |
DE69715208T2 (de) | 2003-04-17 |
NO985202L (no) | 1999-01-08 |
ATE223216T1 (de) | 2002-09-15 |
WO1997041853A1 (fr) | 1997-11-13 |
EP0913151A4 (en) | 2001-01-17 |
AU711128B2 (en) | 1999-10-07 |
DK0913151T3 (da) | 2002-10-14 |
US6180621B1 (en) | 2001-01-30 |
RU2173147C2 (ru) | 2001-09-10 |
CZ363598A3 (cs) | 1999-04-14 |
NO985202D0 (no) | 1998-11-06 |
DE69715208D1 (de) | 2002-10-10 |
AU2651597A (en) | 1997-11-26 |
EP0913151A1 (en) | 1999-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1004578A3 (en) | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives | |
GR3017243T3 (en) | Antiemetic and migraine suppressing heterocyclic compounds and pharmaceutical compositions containing them. | |
PT928788E (pt) | Compostos farmaceuticamente activos | |
MY113733A (en) | Salts of an anti-migraine indole derivative | |
PH25859A (en) | Composition for treatment of ischemic disorder | |
ES2103027T3 (es) | Derivados de tienopiridina y composiciones farmaceuticas que los contienen. | |
HUT59410A (en) | Process for producing 1-methyl carbapenem derivatives and pharmaceutical compositions comprising same as active ingredient | |
EP0467856A3 (en) | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | |
AU2044697A (en) | Phenylalkylcarboxylic acid derivatives | |
EP1172107A4 (en) | MEDICINES CONTAINING SULFOPYRANOSYLACYLGLYCEROL DERIVATIVES | |
IL136100A0 (en) | Biphenylamidine derivatives, prodrugs thereof and pharmaceutical compositions containing the same | |
HK1019710A1 (en) | Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient | |
EP0529452A3 (de) | 1,7-anellierte 2-(Piperazino-alkyl)indol-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
HK1000598A1 (en) | Derivatives of hexahydroazepines procedure for their preparation and pharmaceutical compositions containing same | |
EP1034783A4 (en) | AMIDE DERIVATIVES | |
IL148196A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
HU9203849D0 (en) | Thiazole derivatives | |
GR3007219T3 (xx) | ||
TW280810B (xx) | ||
MY109729A (en) | Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same | |
AU657423B2 (en) | Novel piperidine derivatives and process for preparation thereof | |
HU9401159D0 (en) | New compound leustroducsin h, its preparation and pharmaceutical compositions containing them | |
MXPA99003849A (es) | Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20060508 |